You have 9 free searches left this month | for more free features.

cladribine

Showing 26 - 50 of 67

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

Active, not recruiting
  • Multiple Sclerosis
  • Cladribine
  • Alexandroupolis, Greece
  • +52 more
Sep 28, 2022

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Trial (Cladribine)

Not yet recruiting
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Cladribine
  • (no location specified)
Dec 17, 2020

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Cladribine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Cladribine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Cladribine
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Interferon-beta (IFN-beta))

Completed
  • Multiple Sclerosis
  • Cladribine
  • +2 more
  • Cullman, Alabama
  • +38 more
Oct 8, 2020

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo)

Completed
  • Relapsing-Remitting Multiple Sclerosis
  • Cladribine
  • Placebo
  • Boulder, Colorado
  • +116 more
Nov 10, 2020

Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Tucson (rituximab, bortezomib, cladribine)

Completed
  • Lymphoma
  • +3 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 16, 2019

Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Trial in Houston (drug, other, biological)

Recruiting
  • Hairy Cell Leukemia
  • Recurrent Hairy Cell Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 20, 2020

Acute Myeloid Leukemia, Relapse Leukemia Trial in Guangzhou (Cladribine, G-CSF, Aclarubicin)

Unknown status
  • Acute Myeloid Leukemia
  • Relapse Leukemia
  • Cladribine
  • +3 more
  • Guangzhou, Guangdong, China
    Liang Wang
Aug 18, 2019

Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)

Unknown status
  • Acute Lymphoblastic Leukemia
  • Cladribine
  • +3 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 18, 2019

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Cladribine
  • +13 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021

Acute Biphenotypic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in Seattle

Completed
  • Acute Biphenotypic Leukemia
  • +5 more
  • Cladribine
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 26, 2019

Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Completed
  • Mixed Phenotype Acute Leukemia
  • +6 more
  • Cladribine
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 21, 2020

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Rebif® new formulation (RNF))

Completed
  • Multiple Sclerosis
  • Cladribine
  • +2 more
  • Phoenix, Arizona
  • +157 more
Feb 24, 2021

Acute Myeloid Leukemia Trial in Saint Louis (Selinexor, Cladribine, G-CSF)

Completed
  • Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 6, 2020

Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +38 more
Dec 25, 2021

AML, Relapse Trial in Berne (Epacadostat, Cladribine, Cytarabine)

Withdrawn
  • AML
  • Relapse
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Sep 7, 2018

Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial (Chidamide, Cladribine, gemcitabine)

Unknown status
  • Hodgkin Lymphoma
  • Non-hodgkin Lymphoma
  • (no location specified)
Jul 25, 2018

Lymphocytic Leukemia, Chronic Trial in Belarus, Poland (Cladribine, Cyclophosphamide, Rituximab)

Completed
  • Lymphocytic Leukemia, Chronic
  • Cladribine
  • +2 more
  • Minsk, Belarus
  • +5 more
Nov 17, 2017

Lymphoma Trial in China (Chidamide, Cladribine, gemcitabine)

Unknown status
  • Lymphoma
  • Beijing, Beijing, China
  • +17 more
Jul 16, 2018

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Indolent Adult Non-Hodgkin Lymphoma

Completed
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +3 more
  • Cladribine
  • +3 more
  • Portland, Oregon
  • +1 more
Nov 9, 2017

Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma Trial in Milan (Rituximab, Cladribine)

Terminated
  • Chronic Lymphocytic Leukaemia
  • Small Lymphocytic Lymphoma
  • Milan, Italy
    European Institute of Oncology
Jan 30, 2018

Mantle Cell Lymphoma Trial in Hershey (Rituximab, bortezomib, Cladribine)

Unknown status
  • Mantle Cell Lymphoma
  • Hershey, Pennsylvania
  • +1 more
Aug 4, 2017